Biotech · Private company · Gaithersburg, MD, US
Mirecule, Inc.
Track this companyFree. Adds Mirecule, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards5
- A Novel RNA Therapeutics Platform to Treat Facioscapulohumeral Muscular Dystrophy and other Neuromuscular DisordersFiscal year 2026 · $608.8KNIH RePORTER 5R44NS119147-05 · fetched Nov 12, 2026
- Development of an antibody-oligonucleotide conjugate for treatment of Head and Neck Squamous Cell CarcinomaFiscal year 2025 · $896.9KNIH RePORTER 5R44CA291527-02 · fetched Nov 12, 2026
- A Novel RNA Therapeutics Platform to Treat Facioscapulohumeral Muscular Dystrophy and other Neuromuscular DisordersFiscal year 2025 · $1.2MNIH RePORTER 5R44NS119147-04 · fetched Nov 12, 2026
- Development of an antibody-oligonucleotide conjugate for treatment of Head and Neck Squamous Cell CarcinomaFiscal year 2024 · $863.7KNIH RePORTER 1R44CA291527-01A1 · fetched Nov 12, 2026
- A Novel RNA Therapeutics Platform to Treat Facioscapulohumeral Muscular Dystrophy and other Neuromuscular DisordersFiscal year 2024 · $1.2MNIH RePORTER 4R44NS119147-03 · fetched Nov 12, 2026